Orloff SL - Search Results

1

Fatal fulminant hepatitis associated with bromfenac use.

Rabkin JM, Smith MJ, Orloff SL, Corless CL, Stenzel P, Olyaei AJ. Rabkin JM, et al. Among authors: orloff sl. Ann Pharmacother. 1999 Sep;33(9):945-7. doi: 10.1345/aph.18364. Ann Pharmacother. 1999. PMID: 10492497

2

Liver transplantation for disulfiram-induced hepatic failure.

Rabkin JM, Corless CL, Orloff SL, Benner KG, Flora KD, Rosen HR, Olyaei AJ. Rabkin JM, et al. Among authors: orloff sl. Am J Gastroenterol. 1998 May;93(5):830-1. doi: 10.1111/j.1572-0241.1998.235_a.x. Am J Gastroenterol. 1998. PMID: 9625138

3

High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure.

Estes JD, Stolpman D, Olyaei A, Corless CL, Ham JM, Schwartz JM, Orloff SL. Estes JD, et al. Among authors: orloff sl. Arch Surg. 2003 Aug;138(8):852-8. doi: 10.1001/archsurg.138.8.852. Arch Surg. 2003. PMID: 12912743

4

Tolerance induced by bone marrow chimerism prevents transplant vascular sclerosis in a rat model of small bowel transplant chronic rejection.

Orloff SL, Yin Q, Corless CL, Orloff MS, Rabkin JM, Wagner CR. Orloff SL, et al. Among authors: orloff ms. Transplantation. 2000 Apr 15;69(7):1295-303. doi: 10.1097/00007890-200004150-00015. Transplantation. 2000. PMID: 10798744

5

Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin.

Gopal DV, Rabkin JM, Berk BS, Corless CL, Chou S, Olyaei A, Orloff SL, Rosen HR. Gopal DV, et al. Among authors: orloff sl. Liver Transpl. 2001 Mar;7(3):181-90. doi: 10.1053/jlts.2001.22447. Liver Transpl. 2001. PMID: 11244158 Free article.

6

Prophylactic antiviral therapy in CMV high-risk liver transplant recipients.

Rabkin JM, Rosen HR, Corless CL, Orloff SL, Olyaei AJ. Rabkin JM, et al. Among authors: orloff sl. Transplant Proc. 2001 Feb-Mar;33(1-2):1811-2. doi: 10.1016/s0041-1345(00)02691-9. Transplant Proc. 2001. PMID: 11267523 No abstract available.

7

Late mortality after orthotopic liver transplantation.

Rabkin JM, de La Melena V, Orloff SL, Corless CL, Rosen HR, Olyaei AJ. Rabkin JM, et al. Among authors: orloff sl. Am J Surg. 2001 May;181(5):475-9. doi: 10.1016/s0002-9610(01)00595-5. Am J Surg. 2001. PMID: 11448447

8

Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation.

Rosen HR, Benner KG, Flora KD, Rabkin JM, Orloff SL, Olyaei A, Chou S. Rosen HR, et al. Among authors: orloff sl. Transplantation. 1997 Feb 15;63(3):476-8. doi: 10.1097/00007890-199702150-00026. Transplantation. 1997. PMID: 9039944 No abstract available.

9

Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C.

Rosen HR, Chou S, Corless CL, Gretch DR, Flora KD, Boudousquie A, Orloff SL, Rabkin JM, Benner KG. Rosen HR, et al. Among authors: orloff sl. Transplantation. 1997 Sep 15;64(5):721-6. doi: 10.1097/00007890-199709150-00010. Transplantation. 1997. PMID: 9311709

10

Biliary tract complications of side-to-side without T tube versus end-to-end with or without T tube choledochocholedochostomy in liver transplant recipients.

Rabkin JM, Orloff SL, Reed MH, Wheeler LJ, Corless CL, Benner KG, Flora KD, Rosen HR, Olyaei AJ. Rabkin JM, et al. Among authors: orloff sl. Transplantation. 1998 Jan 27;65(2):193-9. doi: 10.1097/00007890-199801270-00008. Transplantation. 1998. PMID: 9458013

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters